Received Apr 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
received a dose of Boostrix instead of a DTap vaccine; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of wrong vaccine administered in a 6-year-old patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis. Co-suspect products included DTPa (DTPa vaccine) for prophylaxis. On an unknown date, the patient received Boostrix and DTPa vaccine. On an unknown date, an unknown time after receiving Boostrix and DTPa vaccine, the patient experienced wrong vaccine administered (Verbatim: received a dose of Boostrix instead of a DTap vaccine). The outcome of the wrong vaccine administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 22-APR-2025 Other HCP reported that a 6-year-old patient had received a dose of Boostrix instead of a DTap vaccine (no brand name reported), which led to wrong vaccine administered. Reporter didn't have any more additional details on this event.